Clinical Trial Background Issues - page 3
Clinical Trial Design
Randomized Controlled Trials (RCTs)
RCTs have become the gold standard for clinical research. To establish causality between the intervention (e.g., a drug) and the outcome (e. g., overall survival), researchers try to make sure that one can assume that the experimental and control arms are similar in every way except for the intervention.
This is sometimes referred to as balancing the groups, and ensures that no superfluous variables are confounding, (produce results that seem to be caused by the intervention when they really aren't). Three techniques to avoid confounding are discussed below.
Randomization is a method of assigning patients to treatment arms by chance, avoiding any systematic imbalance in characteristics between patients who will receive the experimental intervention versus those that receive the control intervention.
![]() |
Patients are usually assigned equally to all arms, although this need not be the case.
With a simple two-arm trial (one experimental and one control arm) randomization can be accomplished with a flip of a coin.
When there are more than two arms, or unequal numbers of patients are to be assigned to different arms, computer algorithms can be used to ensure random assignment.
Blinding
Blinding is a means of ensuring that neither patients, healthcare providers, nor researchers know which group specific patients are assigned.
Trials are said to be single (the patient does not know), double (the patient and the investigator do not know), or triple blinded (the patient, investigator and assessors do not know if participant is receiving the new intervention), depending upon how many of the relevant participants in the trial are unaware of patient assignment.
The purpose of blinding is to minimize the chance that patients receive different care, or their data is interpreted differently, based upon the intervention to which they are assigned.